RESUMEN
Cross and co-resistance to antimicrobials are presented for 765 Danish Escherichia coli isolates of porcine origin from 2009 to 2013. All isolates and data originate from the DANMAP surveillance but have not previously been used to describe the occurrence of cross and co- resistance. Data presented here clearly indicate the ability of low classified antimicrobials as ampicillin to uphold resistance to critical important antimicrobials for human treatment.
Asunto(s)
Farmacorresistencia Bacteriana , Infecciones por Escherichia coli/veterinaria , Pruebas de Sensibilidad Microbiana/veterinaria , Enfermedades de los Porcinos/tratamiento farmacológico , Ampicilina , Animales , Antibacterianos , Antiinfecciosos , Escherichia coli , Infecciones por Escherichia coli/tratamiento farmacológico , Humanos , PorcinosRESUMEN
On the basis of 98 case reports compiled from the literature of the years 1902 to 1984, a retrospective study was conducted on 454 tumors developed after radiotherapy within the irradiation field. 226 patients (49.8%) were treated for a benign primary disease and 222 (49.6%) for a malignant primary disease. In six cases the primary diagnosis was unknown. The histologic investigation of the tumors showed sarcomas in 52% of the cases, carcinomas in 38%, and leukemias in 8.5%. Cerebral tumors were described in two cases. The average latency was 7.1 years in leukemia, 12.1 years in sarcomas, and 19 years in carcinomas. Carcinomas were preponderantly found after a focal dose up to 30 Gy, sarcomas after higher doses up to 70 Gy. In leukemia, a dose-effect correlation was not evident. The influence of surgery, chemotherapy, the age of the patients at the moment of radiotherapy, as well as the dignity of the primary disease on latency and histology of the radiogenic tumor was also investigated.
